BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18519951)

  • 1. Lung cancer staging techniques and induction therapy: maybe timing is everything.
    Pass HI
    J Clin Oncol; 2008 Jul; 26(20):3306-7. PubMed ID: 18519951
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
    Besse B; Le Chevalier T
    J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
    [No Abstract]   [Full Text] [Related]  

  • 3. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
    Van Schil PE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
    Socinski MA
    J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
    Avery EJ; Kessinger A; Ganti AK
    Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining prognosis in non-small-cell lung cancer.
    Singh T; Dhindsa J
    N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathologic complete responses after chemotherapy plus figitumumab in stage IV non-small-cell lung cancer.
    Corral J; López-Villalobos JL; Gomez-Izquierdo L; Borrego I; Paz-Ares L
    J Clin Oncol; 2011 Mar; 29(7):e163-5. PubMed ID: 21149666
    [No Abstract]   [Full Text] [Related]  

  • 10. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bronchial carcinoma--percutaneous needle biopsy does not led to mortality].
    Fath R
    Pneumologie; 2007 Sep; 61(9):558. PubMed ID: 17939082
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Paleari L; Russo P; Cesario A; Granone P
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of elderly patients with stage IV non-small-cell lung cancer.
    Weiss J; Stinchcombe TE
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):111-20. PubMed ID: 22149437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary.
    Goldberg M
    Ann Thorac Surg; 2006 Jan; 81(1):304. PubMed ID: 16368386
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative data from lung cancer trial may change practice guidelines, study designs.
    McNeil C
    J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of advanced non-small cell lung neoplasms: a closed debate?].
    Le Guen Y; Soria JC; Ruffié P
    Bull Cancer; 2003 Mar; 90(3):199-201. PubMed ID: 12801821
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
    Bearz A; Serraino D; Fratino L; Berretta M; Tirelli U
    Cancer; 2007 Dec; 110(11):2593-4; author reply 2594. PubMed ID: 17960771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of non-small-cell lung carcinoma: PS2 patients' particularities].
    Deppermann KM
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S31-4S34. PubMed ID: 15687991
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preoperative chemotherapy for lung cancer].
    Suzuki K
    Nihon Rinsho; 2002 May; 60 Suppl 5():438-41. PubMed ID: 12101709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.